ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Radiological, Nuclear Medicine & Hybrid Imaging

Medicine & Life Sciences

• Abdomen 9%
• Biopsy 13%
• Bone and Bones 19%
• Brain 5%
• Diffusion Magnetic Resonance Imaging 12%
• Fluorodeoxyglucose F18 11%
• Glucose 6%
• Guidelines 48%
• Liver 33%
• Lung 5%
• Lymph Nodes 15%
• Magnetic Resonance Imaging 21%
• Multimodal Imaging 100%
• Neck 8%
• Needle Biopsy 11%
• Neoplasm Metastasis 39%
• Neoplasm Staging 23%
• Neuroendocrine Tumors 85%
• Nuclear Medicine 87%
• Pancreas 18%
• Pelvis 10%
• Radionuclide Imaging 10%
• Somatostatin 11%
• Somatostatin Receptors 41%
• Standard of Care 73%
• Therapeutics 1%
• Thorax 14%
• Tomography 51%
• Ultrasonography 50%